Excellence in oncology
Developing an effective biomarker strategy
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients. Payers are able to demonstrate that the treatment they are paying for will be of maximum value. Physicians feel confident that they are offering an effective drug, which is at the cutting-edge of medicine. And patients clearly benefit from a treatment programme that reduces the risk of unnecessary toxicities and offers them better outcomes.
PBIRG Annual National Conference 2013
Naples, Florida, US May 19 -22, 2013
We were delighted to be exhibiting and presenting a paper at this year’s PBIRG Annual General Meeting in Naples, Florida. Directors Tom Winter and Claire Richardson took to the stage to present the paper 'I Just Want to Lead a Normal Life - Harnessing Mobile Research Methods to Improve Our Understanding of Compliance.' The paper looked at the limitations of existing research methods measuring compliance and investigated the use of mobile as a means of delivering better insights.